Notification regarding unquoted securities - PER
Released
Released
Announcement PDF
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Announcement Summary
Entity name
PERCHERON THERAPEUTICS LIMITED
Date of this announcement
Monday November 25, 2024
The +securities the subject of this notification are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are
not quoted, and are not intended to be quoted, on ASX
Total number of +securities to be issued/transferred
ASX +security
code
Security description
New class - code
to be confirmed
Unquoted options exercisable at $0.083 per share
on or before 4 July 2029
Total number of
+securities to be
issued/transferred
Issue date
6,000,000
25/11/2024
Refer to next page for full details of the announcement
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
1/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 1 - Entity and announcement details
1.1 Name of entity
PERCHERON THERAPEUTICS LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 Registered number type
Registration number
ABN
41095060745
1.3 ASX issuer code
PER
1.4 The announcement is
New announcement
1.5 Date of this announcement
25/11/2024
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
2/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 2 - Issue details
2.1 The +securities the subject of this notification are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are
not quoted, and are not intended to be quoted, on ASX
Previous Appendix 3B details:
Announcement Date and
Time
Announcement Title
Selected Appendix 3B to submit quotation
request
21-Nov-2024 15:03
New - Proposed issue of securities PER
A placement or other type of issue
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the
Appendix 3B?
No
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
3/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 3A - number and type of +securities the subject of this notification (existing class or new class) where issue has previously been
notified to ASX in an Appendix 3B
Placement Details
ASX +security code and description
new unquoted class of security
Date the +securities the subject of this notification were issued
25/11/2024
Any other information the entity wishes to provide about the +securities the subject of this notification
Issue details
Number of +securities
3,000,000
Were the +securities issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
The options were issued to Dr James Garner in accordance with Resolution 3 as approved by the shareholders at the
2024 Percheron Therapeutics Annual General Meeting held on 21 November 2024
Number of +securities
3,000,000
Were the +securities issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
The options were issued to Dr Ben Gil Price in accordance with Resolution 4 as approved by the shareholders at the 2024
Percheron Therapeutics Annual General Meeting held on 21 November 2024
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
4/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 3C - number and type of +securities the subject of this notification (new class)
ASX +security code
+Security description
New class - code to be confirmed
Unquoted options exercisable at $0.083 per share on or
before 4 July 2029
+Security type
ISIN code
Options
Date the +securities the subject of this notification were issued
25/11/2024
Will all the +securities issued in this class rank equally in all respects from their issue date?
Yes
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under
listing rule 6.1?
No
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being
issued.
Please see 2024 Percheron Therapeutics Notice of Annual General Meeting https://percherontx.com/investors/asx-annou
ncements/
Options Details
+Security currency
Exercise price
Expiry date
AUD - Australian Dollar
AUD 0.08300000
4/7/2029
Details of the existing class of +security that will be issued upon exercise or conversion of this new class of
company option
PER : ORDINARY FULLY PAID
Any other information the entity wishes to provide about the +securities the subject of this notification
Issue details
Number of +securities
3,000,000
Number of +securities
3,000,000
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
5/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 4 - +Securities on issue
Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of
the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if
other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
PER : ORDINARY FULLY PAID
1,059,937,633
4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
PERAF : OPTION EXPIRING 20-DEC-2024 EX $0.48
83,386,886
PERAI : OPTION EXPIRING 07-AUG-2028 EX $0.07
6,690,000
PERAJ : OPTION EXPIRING 30-JUN-2028 EX $0.061
3,000,000
PERAK : OPTION EXPIRING 04-JUL-2029 EX $0.083
8,400,000
PERAC : OPTION EXPIRING 18-MAR-2025 EX $0.185
4,000,000
PERAD : OPTION EXPIRING 18-MAR-2025 EX $0.27
10,500,000
New class - code to be confirmed : Unquoted options exercisable at $0.083 per share on or
before 4 July 2029
6,000,000
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
6/6
Share your feedback
Discover